Age, Phenotype, and Curability in Acute Myelogenous Leukemia
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 9 (6) , 655-657
- https://doi.org/10.3109/07357909109039877
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequencesBlood, 1989
- Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes.Proceedings of the National Academy of Sciences, 1989
- Acute promyelocytic leukemia: treatment results during a decade at Memorial HospitalBlood, 1989
- French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982–1983 and classified according to FAB criteriaCancer, 1987
- Acute promyelocytic leukemiaThe American Journal of Medicine, 1986
- Improved treatment results in childhood acute myelogenous leukemia: a report of the German cooperative study AML-BFM-78Blood, 1985
- The Fourth International Workshop on Chromosomes in LeukemiaCancer Genetics and Cytogenetics, 1984
- Association of an Inversion of Chromosome 16 with Abnormal Marrow Eosinophils in Acute Myelomonocytic LeukemiaNew England Journal of Medicine, 1983
- Chemotherapy for acute myelogenous leukemia in children and adults: VAPA updateBlood, 1983
- A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotypeBlood, 1982